Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Graham, K. A. Articles by Perkins, D. O. Search for Related Content PubMed Citation Articles by Graham, K. A. Articles by Perkins, D. O. Neurotransmitters Bipolar Disorder Atypical Neuroleptics Schizophrenia Spectrum Disorders Other Somatic Therapy

Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects Who Gained Weight With Olanzapine

OBJECTIVE: This study sought to determine if amantadine affects weight gain in psychiatric patients taking olanzapine. METHOD: Twenty-one adults who had gained at least 5 lb with olanzapine were randomly assigned to receive amantadine (N=12) or placebo (N=9) in addition to olanzapine. The length of time taking olanzapine ranged from 1 to 44 months. Body mass index, psychiatric status, and fasting blood levels were assessed at baseline and 12 weeks. RESULTS: Significantly fewer subjects taking amantadine gained weight, with a mean change in body mass index of –0.07 kg/m² for the amantadine group and 1.24 kg/m² for the placebo group. This effect remained significant when the authors controlled for baseline body mass index and length of olanzapine treatment. No changes in fasting glucose, insulin, leptin, prolactin, and lipid levels were seen. Positive and Negative Syndrome Scale scores remained stable. CONCLUSIONS: Amantadine induced weight stabilization in subjects taking olanzapine and was well tolerated.

This article has been cited by other articles:

				A. R. Ruelaz Psychiatric Involvement in Obesity Treatment Focus, July 1, 2009; 7(3): 311 - 316. [Abstract] [Full Text] [PDF]

				W. S. Fenton and M. R. Chavez Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia Focus, April 1, 2008; 6(2): 246 - 253. [Abstract] [Full Text] [PDF]

				D. J. Klein, E. M. Cottingham, M. Sorter, B. A. Barton, and J. A. Morrison A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents Am J Psychiatry, December 1, 2006; 163(12): 2072 - 2079. [Abstract] [Full Text] [PDF]

				W. S. Fenton and M. R. Chavez Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia Am J Psychiatry, October 1, 2006; 163(10): 1697 - 1704. [Full Text] [PDF]

				J. Arehart-Treichel Drug Fights Weight Gain Induced by Antipsychotics Psychiatr News, October 7, 2005; 40(19): 27 - 27. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us